Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant Melanoma.

Akturk, Halis Kaan; Couts, Kasey L; Baschal, Erin E; Karakus, Kagan E; Van Gulick, Robert J; Turner, Jacqueline A; Pyle, Laura; Robinson, William A; Michels, Aaron W

Akturk, Halis Kaan; Couts, Kasey L; Baschal, Erin E; Karakus, Kagan E; Van Gulick, Robert J; Turner, Jacqueline A; Pyle, Laura; Robinson, William A; Michels, Aaron W.

Afiliación

Akturk HK; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora.
Couts KL; Department of Pediatrics, University of Colorado School of Medicine, Aurora.
Baschal EE; Department of Medicine, University of Colorado School of Medicine, Aurora.
Karakus KE; Department of Medicine, University of Colorado School of Medicine, Aurora.
Van Gulick RJ; University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora.
Turner JA; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora.
Pyle L; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora.
Robinson WA; Department of Medicine, University of Colorado School of Medicine, Aurora.
Michels AW; Department of Medicine, University of Colorado School of Medicine, Aurora.

JAMA Netw Open ; 5(12): e2246400, 2022 12 01.

Article en En | MEDLINE | ID: mdl-36512357

Asunto(s)

Antineoplásicos Inmunológicos; Antígenos HLA-DR; Inhibidores de Puntos de Control Inmunológico; Melanoma; Femenino; Humanos; Masculino; Persona de Mediana Edad; Alelos; Antineoplásicos Inmunológicos/efectos adversos; Estudios de Casos y Controles; Antígenos HLA-DR/genética; Inhibidores de Puntos de Control Inmunológico/efectos adversos; Melanoma/tratamiento farmacológico; Melanoma/genética; Melanoma Cutáneo Maligno

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antígenos HLA-DR / Antineoplásicos Inmunológicos / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google